Drugs.com - News for Health Professionals Headline news from Drugs.com. Comprehensive, up-to-date drug news for healthcare professionals.

  • CDC: Buprenorphine Treatment Differs in Urban, Rural Areas
    on September 1, 2026 at 10:56 pm

    TUESDAY, Sept. 1, 2026 -- Buprenorphine access and treatment differ between urban and rural areas, according to research published in the Aug. 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly...

  • Cancer Risk ID'd for Asian American, NHPI Population
    on September 1, 2026 at 10:54 pm

    TUESDAY, Sept. 1, 2026 -- Considerable differences are seen in the incidence of cancers among Asian American and Native Hawaiian and Pacific Islander (NHPI) people, according to a study published online Aug. 27 in Cancer.Nikita Sandeep Wagle...

  • FDA Approves Lisraya for Dermatomyositis in Adults
    on September 1, 2026 at 3:09 pm

    TUESDAY, Sept. 1, 2026 -- The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment of dermatomyositis in adults. The approval was based on results from a phase 3 trial in which 241 adults with...

  • Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
    on September 1, 2026 at 3:09 pm

    TUESDAY, Sept. 1, 2026 -- Lower predicted prevalences of birth defects are seen in association with periconception parental vitamin B12 and postconception maternal red blood cell (RBC) folate, according to a study published online Sept. 1 in the...

  • ESC: Artificial Sweetener Linked to Increased Risk for Major Cardiovascular Events
    on September 1, 2026 at 2:09 pm

    TUESDAY, Sept. 1, 2026 -- The artificial sweetener xylitol is independently associated with the incident risk for major adverse cardiovascular events (MACE) in the general population, according to a study presented at the annual meeting of the...